Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer

Kishi, N; Matsuo, Y; Shintani, T; Ogura, M; Mitsuyoshi, T; Araki, N; Fujii, K; Okumura, S; Nakamatsu, K; Kishi, T; Atsuta, T; Sakamoto, T; Ohtsu, S; Katagiri, T; Narabayashi, M; Fujishiro, S; Iizuka, Y; Ozasa, H; Hirai, T; Mizowaki, T

Matsuo, Y (通讯作者)，Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.

JOURNAL OF RADIATION RESEARCH, 2023; 64 (1): 142

Abstract

Chemoradiotherapy followed by consolidation durvalumab (CCRT+D) improves survival in patients with stage III non-small-cell lung cancer (NSCLC). We co......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索